Genitourinary Cancer
Radiation and Cancer Biology
AMA PRA Category 1 Credits 1.00
CAMPEP Credits: 1.00
MDCB Credits: 1.00
Craig Grossman, MD, PhD, MS
University of South Florida Morsani College of Medicine
Tampa, FL
Radiation therapy-induced erectile dysfunction (RI-ED) occurs in over 50% of men treated for prostate cancer. The etiologies are likely multifactorial, consisting of a neurological, vascular and endocrine component. Since RI-ED significantly impacts quality of life and therefore may influence a patients decision to pursue radiation treatment, understanding the pathophysiology, preventative measures, and treatment options are important for both the patient and the health care provider. Specific guidelines for RI-ED prevention and rehabilitation in prostate cancer patients have been lacking. However, with the evolution of CT- and MR-guided radiotherapy, novel brachytherapy techniques, and drugs to alter erectile hemodynamics, attempts are being made to mitigate the sexual toxicities of radiotherapy and androgen deprivation therapy.
Speaker: Craig Grossman, MD, PhD, MS – University of South Florida Morsani College of Medicine
Speaker: Susan LaRue, DVM, PhD – Colorado State University
Speaker: William McLaughlin, MD – University of Michigan
Speaker: John Mulhall, MD – MSKCC
Speaker: Alexander Pastuszak, MD, PhD – University of Utah School of Medicine
Speaker: Craig Grossman, MD, PhD, MS – University of South Florida Morsani College of Medicine